HIM
OCDX

Hillsdale Investment Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Hillsdale Investment Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,600
Closed -$997K – 640
2021
Q4 		$997K Sell
46,600
-5,000
-10% -$98.5K 0.07% 255
2021
Q3 		$954K Hold
51,600
– – 0.07% 257
2021
Q2 		$1.1M Buy
+51,600
New +$1.05M 0.09% 217

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Hillsdale Investment Management's OCDX Position: Q1 2022 in Review

Hillsdale Investment Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 46,600 shares — an estimated $997K sold.

Hillsdale Investment Management first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $1.1M in Q2 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Hillsdale Investment Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 46,600 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $997K.
  • Hillsdale Investment Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
  • Hillsdale Investment Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.1M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.